Vahid Zia

Vahid Zia is the Head of Product Development at Revolution Medicines, responsible for leading the end-to-end development and commercialization of drug products from discovery to market launch. Prior to this role, Zia served as an Advisory Board Member for the CPPR Center for Pharmaceutical Processing Research, fostering collaborative research between industrial and academic scientists. Zia was also an Industrial Research Adviser at The University of Kansas and an Executive Director of Product Development at Gilead Sciences, where oversight included a department of over 90 scientists and the management of commercialization strategies for small molecule drug products. Additionally, Zia contributed as an Adjunct Faculty member at North Carolina Agricultural and Technical State University, developing a course in drug development. Zia holds a PhD in Pharmaceutical Chemistry from The University of Kansas and a BS in Pharmacy from the University of Rhode Island.